You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FXR

Showing 1 - 25 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Alcoholic Hepatitis (sAH) Trial in Baltimore (INT-787)

Recruiting
  • Severe Alcoholic Hepatitis (sAH)
  • Baltimore, Maryland
    Mercy Medical Center
Jan 5, 2023

Human Immunodeficiency Virus I Infection Trial in Lyon (Blood collection.)

Not yet recruiting
  • Human Immunodeficiency Virus I Infection
  • Blood collection.
  • Lyon, France
    Service des maladies infectieuses et tropicales Hôpital de la Cr
Jan 21, 2022

Farnesoid X Receptor Ligands on Reactivation of Latent Provirus

Completed
  • Hiv
  • Blood sampling
  • Lyon, France
    Service des maladies infectieuses et tropicales - Hôpital de la
Jul 28, 2021

Healthy Volunteer Trial in San Antonio (ASC43F)

Completed
  • Healthy Volunteer
  • San Antonio, Texas
    8307 Gault Lane
Dec 16, 2021

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

NASH - Nonalcoholic Steatohepatitis, Healthy Trial in Randwick (EYP001a)

Completed
  • NASH - Nonalcoholic Steatohepatitis
  • Healthy
  • Randwick, New South Wales, Australia
    ENYO Pharma clinical site
Sep 24, 2020

Hepatitis B, Chronic Trial in Worldwide (EYP001a, Placebo, Entecavir)

Active, not recruiting
  • Hepatitis B, Chronic
  • Brisbane, Australia
  • +17 more
May 12, 2021

FGF19 in Obstructive Cholestasis: "Unveil the Signal"

Recruiting
  • Cholestasis
  • +4 more
  • Biospecimen sampling
  • Aachen, Germany
    RWTH Aachen
Feb 6, 2023

Non-alcoholic Steatohepatitis Trial in Tanta (Obeticholic Acid Oral Tablet, Vit E)

Active, not recruiting
  • Non-alcoholic Steatohepatitis
  • Obeticholic Acid Oral Tablet
  • Vit E
  • Tanta, Egypt
    Department of Tropical Medicine and Infectious Diseases, Faculty
Oct 6, 2022

Healthy Trial in Leuven (Ocaliva, Placebo)

Recruiting
  • Healthy
  • Leuven, Vlaams-Brabant, Belgium
    KU Leuven
Feb 13, 2023

Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule

Recruiting
  • Drug-Induced Liver Injury
  • +2 more
  • MT2004 Capsule
  • MT2004 Capsule Placebo
  • Shanghai, Shanghai, China
    Shanghai Jiaotong University School of Medicine,Renji Hospital
Aug 25, 2023

Barrett Esophagus Trial (Obeticholic Acid, Placebo Administration)

Not yet recruiting
  • Barrett Esophagus
  • Obeticholic Acid
  • Placebo Administration
  • (no location specified)
Oct 13, 2022

Nonalcoholic Steatohepatitis (NASH) Trial (CS0159 (Linafexor))

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • CS0159 (Linafexor)
  • (no location specified)
Nov 14, 2022

Biliary Atresia Trial in Worldwide (OCA 0.1mg, OCA 1.5mg, OCA 5mg)

Active, not recruiting
  • Biliary Atresia
  • OCA 0.1mg
  • +2 more
  • Brussel, Belgium
  • +16 more
May 6, 2022

Colorectal Cancer Trial in Duarte (biological, drug, genetic, other, procedure)

Active, not recruiting
  • Colorectal Cancer
  • bevacizumab
  • +13 more
  • Duarte, California
    City of Hope Medical Center
Sep 3, 2021

Healthy Trial in Changsha (ASC42, Placebo)

Completed
  • Healthy
  • Changsha, Hunan, China
    Xiangya Boai Rehabilitation Hospital
Jun 28, 2022

Healthy Participants Trial in Glendale (ID119031166M, Placebo)

Recruiting
  • Healthy Participants
  • Glendale, California
    California Clinical trials medical group/PAREXEL
Oct 28, 2022

Non-Alcoholic Fatty Liver Disease Trial in Dhaka (Obeticholic acid)

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Obeticholic acid
  • Dhaka, Bangladesh
    Department of Hepatology
May 15, 2022

Non-alcoholic Steatohepatitis (NASH) Trial in Worldwide (Tropifexor (LJN452), Placebo)

Terminated
Has Results
  • Non-alcoholic Steatohepatitis (NASH)
  • Tropifexor (LJN452)
  • Placebo
  • Madison, Alabama
  • +80 more
Aug 11, 2021

NASH - Nonalcoholic Steatohepatitis Trial in San Antonio (TERN-501, TERN-101, Placebo)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Chandler, Arizona
  • +21 more
Jan 6, 2023

Intrahepatic Cholestasis of Pregnancy and Diabetes Mellitus

Active, not recruiting
  • Intrahepatic Cholestasis of Pregnancy
  • Gestational Diabetes Mellitus
    • London, United Kingdom
    • +1 more
    Aug 25, 2021

    Obesity Trial in Göteborg (Obeticholic acid, Obeticholic acid )

    Unknown status
    • Obesity
    • Obeticholic acid
    • Obeticholic acid placebo
    • Göteborg, Sweden
    • +1 more
    Aug 22, 2020

    Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

    Not yet recruiting
    • Myeloproliferative Neoplasms (MPNs)
    • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
    • (no location specified)
    Mar 24, 2023

    Liver Disease Trial in United States (triopifexor, Placebo)

    Completed
    • Liver Disease
    • Madison, Alabama
    • +9 more
    Feb 7, 2022

    Non-Alcoholic Fatty Liver Disease Trial in Porto (BAR502, Placebo)

    Not yet recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Porto, Portugal
      BlueClinical Phase I
    Jan 5, 2022